314 logo

Sipai Health Technology Co., Ltd. Stock Price

SEHK:314 Community·HK$1.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

314 Share Price Performance

HK$1.41
-4.38 (-75.65%)
HK$1.41
-4.38 (-75.65%)
Price HK$1.41

314 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

0 Risks
1 Reward

Sipai Health Technology Co., Ltd. Key Details

CN¥2.1b

Revenue

CN¥1.8b

Cost of Revenue

CN¥310.2m

Gross Profit

CN¥434.5m

Other Expenses

-CN¥124.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 20, 2026
-0.17
14.98%
-6.00%
0%
View Full Analysis

About 314

Founded
2014
Employees
3131
CEO
Xuguang Ma
WebsiteView website
www.medbankshealthtech.com

Sipai Health Technology Co., Ltd., together with its subsidiaries, operates as a medical technology and health management company in the People’s Republic of China. It operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Commercial Insurance Services Business. The company operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. It also provides site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and other services to pharmaceutical companies and other clinical trial institutions; and services for image management in clinical trials. In addition, the company offers insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. Further, it is involved in retail of pharmaceutical products; and provision of pharmacist and physician research assistance services. The company was founded in 2014 and is based in Shanghai, the People’s Republic of China.

Recent 314 News & Updates

Recent updates

No updates